Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
Tsumura H, Tanaka N, Oguchi T, Owari T, Nakai Y, Asakawa I, Iijima K, Kato H, Hashida I, Tabata KI, Satoh T, Ishiyama H. Tsumura H, et al. Among authors: tabata ki. Radiat Oncol. 2022 Apr 11;17(1):71. doi: 10.1186/s13014-022-02046-x. Radiat Oncol. 2022. PMID: 35410307 Free PMC article.
Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, Okusa H, Tabata K, Baba S, Hayakawa K. Ishiyama H, et al. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):23-8. doi: 10.1016/j.ijrobp.2008.11.006. Epub 2009 Feb 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19243900
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up.
Ishiyama H, Satoh T, Kitano M, Tabata K, Komori S, Ikeda M, Soda I, Kurosaka S, Sekiguchi A, Kimura M, Kawakami S, Iwamura M, Hayakawa K. Ishiyama H, et al. J Radiat Res. 2014 May;55(3):509-17. doi: 10.1093/jrr/rrt128. Epub 2013 Nov 11. J Radiat Res. 2014. PMID: 24222312 Free PMC article. Clinical Trial.
Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy.
Kawakami S, Ishiyama H, Satoh T, Tsumura H, Sekiguchi A, Takenaka K, Tabata KI, Iwamura M, Hayakawa K. Kawakami S, et al. Among authors: tabata ki. J Contemp Brachytherapy. 2017 Aug;9(4):316-322. doi: 10.5114/jcb.2017.69807. Epub 2017 Aug 30. J Contemp Brachytherapy. 2017. PMID: 28951750 Free PMC article.
A cold spot compensation technique using a combination of trans-rectal ultrasonography and intraoperative computed tomography for interstitial permanent prostate brachytherapy: a single-arm prospective trial.
Ishiyama H, Tsumura H, Kawakami S, Satoh T, Sekiguchi A, Tabata KI, Iwamura M, Hayakawa K. Ishiyama H, et al. Among authors: tabata ki. J Contemp Brachytherapy. 2018 Feb;10(1):10-16. doi: 10.5114/jcb.2018.74319. Epub 2018 Feb 28. J Contemp Brachytherapy. 2018. PMID: 29619051 Free PMC article.
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
Yokomizo A, Koga H, Ito K, Takezawa Y, Komiyama M, Nishimura K, Yonese J, Hashine K, Masumori N, Arai G, Saito S, Shinohara M, Shimizu N, Yamauchi A, Satoh T, Tochigi T, Kobayashi M, Fujimoto H, Kakimoto KI, Fukui I, Tsukamoto T, Nozaki M, Karasawa K, Hasumi M, Ohtani M, Ishiyama H, Kuwahara M, Harada M, Ohashi Y, Kotake T, Kakizoe T, Suzuki K, Naito S, Yamanaka H; National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators. Yokomizo A, et al. Cancer Med. 2021 May;10(10):3240-3248. doi: 10.1002/cam4.3895. Epub 2021 May 1. Cancer Med. 2021. PMID: 33932114 Free PMC article. Clinical Trial.
[8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer].
Tabata K, Satoh T, Matsumoto K, Fujita T, Irie A, Iwamura M, Yanagisawa N, Matsuda D, Muramoto M, Kadowaki K, Suyama K, Shoji K, Koh H, Kawakami T, Okayasu I, Egawa S, Baba S. Tabata K, et al. Nihon Hinyokika Gakkai Zasshi. 2006 Jul;97(5):712-8. doi: 10.5980/jpnjurol1989.97.712. Nihon Hinyokika Gakkai Zasshi. 2006. PMID: 16898594 Free article. Clinical Trial. Japanese.
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Tsumura H, Satoh T, Ishiyama H, Tabata K, Kotani S, Minamida S, Kimura M, Fujita T, Matsumoto K, Kitano M, Hayakawa K, Baba S. Tsumura H, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e385-92. doi: 10.1016/j.ijrobp.2011.04.026. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21664068 Clinical Trial.
A prospective quasi-randomized comparison of intraoperatively built custom-linked seeds versus loose seeds for prostate brachytherapy.
Ishiyama H, Satoh T, Kawakami S, Tsumura H, Komori S, Tabata K, Sekiguchi A, Takahashi R, Soda I, Takenaka K, Iwamura M, Hayakawa K. Ishiyama H, et al. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):134-9. doi: 10.1016/j.ijrobp.2014.05.009. Epub 2014 Jun 28. Int J Radiat Oncol Biol Phys. 2014. PMID: 24986744 Clinical Trial.
Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer.
Matsubara N, Yamada Y, Tabata KI, Satoh T, Kamiya N, Suzuki H, Kawahara T, Uemura H, Yano A, Kawakami S, Otsuka M, Fukasawa S. Matsubara N, et al. Among authors: tabata ki. Clin Genitourin Cancer. 2018 Apr;16(2):142-148. doi: 10.1016/j.clgc.2017.09.008. Epub 2017 Sep 23. Clin Genitourin Cancer. 2018. PMID: 29042308
Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience.
Matsumoto K, Tabata KI, Hirayama T, Shimura S, Nishi M, Ishii D, Fujita T, Iwamura M. Matsumoto K, et al. Among authors: tabata ki. Asian J Surg. 2019 Jan;42(1):189-196. doi: 10.1016/j.asjsur.2017.11.002. Epub 2017 Dec 15. Asian J Surg. 2019. PMID: 29254869 Free article.
Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study.
Kawahara T, Yoneyama S, Ohno Y, Iizuka J, Hashimoto Y, Tsumura H, Tabata KI, Nakagami Y, Tanabe K, Iwamura M, Uemura H, Miyoshi Y. Kawahara T, et al. Among authors: tabata ki. Biomed Res Int. 2020 Jul 1;2020:7804932. doi: 10.1155/2020/7804932. eCollection 2020. Biomed Res Int. 2020. PMID: 32714984 Free PMC article.
Laparoscopic adrenalectomy for metastatic adrenal tumor.
Hirayama T, Fujita T, Koguchi D, Nishi M, Kurosaka S, Tsumura H, Tabata K, Iwamura M. Hirayama T, et al. Asian J Endosc Surg. 2014 Jan;7(1):43-7. doi: 10.1111/ases.12076. Epub 2013 Nov 20. Asian J Endosc Surg. 2014. PMID: 24251723
138 results